The Differential Hemodynamic Effects of Norepinephrine and Methoxamine in Systemic Hypotension Complicating Pulmonary Hypertension

Abstract

The authors investigated the acute cardiopulmonary effects of noradrenaline and methoxamine in a canine model in which systemic hypotension complicated an acute increase in pulmonary vascular resistance. In 13 anesthetized ventilated dogs, glass beads were injected to increase right ventricular afterload and to decrease mean blood pressure to approximately 65 mmHg. In the first 7 dogs, corresponding to the decrease in blood pressure, there was a marked fall in cardiac output, from 4.8 to 1 L/minute (P < 0.01). Subsequently, dogs were treated in sequence with norepinephrine and then with methoxamine. Both drugs caused a similar increase in mean blood pressure, from approximately 66 to 121 mmHg (both P < 0.001) and in right ventricular coronary perfusion pressure. However, only norepinephrine increased cardiac output.

To determine whether the differential effects of these drugs on cardiac output was explained by differences in coronary artery flow, in a second group of 6 dogs, right coronary artery flow was measured before and after pulmonary embolization and during infusion of both drugs. Coronary artery flow decreased when blood pressure decreased with embolization. As above, while both drugs caused a similar increase in blood pressure and right ventricular coronary perfusion pressure, only norepinephrine increased cardiac output. Also, values for coronary artery blood flow were similar during infusion of both drugs. Most likely, the improvement in cardiac output with norepinephrine is explained by a direct inotropic effect of this agent.

Get full access to this article

View all access options for this article.

References

1. Laver MB , Strauss WH , Provost GM : Herbert Shubin Memorial Lecture. Right and left ventricular geometry: Adjustments during acute respiratory failure. Crit Care Med 7:509-519, 1975.

2. Vlahakes GJ , Turley K , Hoffman JIE : The pathophysiology of failure in acute right ventricular hypertension: Hemodynamic and biochemical correlations. Circulation 63:87-95, 1981.

3. Scharf SM , Warner KG , Josa M , et al: Load tolerance of the right ventricle (RV): Effect of increased aortic pressure (Pao). J Crit Care 1:163-172, 1986.

4. Molloy WD , Lee KY , Girling L , et al: Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 130:870-874, 1984.

5. Molloy WD , Lee KY , Jones D , et al: Effects of noradrenaline and isoproterenol on cardiopulmonary function in a canine model of acute pulmonary hypertension. Chest 88:432-435, 1986.

6. Angle MR , Molloy WD , Penner B , et al: The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism. Chest 95:1333-1337, 1989.

7. Levy MN , Brind SH : Influence of 1-norepinephrine upon cardiac output in anesthetized dogs. Circ Res 5:85-89, 1957.

8. Goldberg LI , Bloodwell RD , Braunwald E , et al: The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man. Circulation 22:1125-1132, 1960.

9. Goldberg LI , de V. Cotten M , Dorby TD , et al: Comparative heart contractile force effects of equipressor doses of several sympathomimetic amines. J Pharmacol Exp Ther 108:177-185, 1953.

10.

10. Stein PD , Sabbath HN , Anbe DT , et al: Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension. Am J Cardiol 44:1050-1055, 1979.

11.

11. Ghignone M , Girling L , Prewitt RM : Effect of increased pulmonary vascular resistance on right ventricular systolic performance in dogs. Am J Physiol 246 (Heart Circ Physiol 15):H339-H343, 1984.

12.

12. Hurford WE , Barlai-Kovach M , Strauss HW , et al: Canine biventricular performance during acute progressive pulmonary microembolization: Regional myocardial perfusion and fatty acid uptake. J Crit Care 2:270-281, 1987.